Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Bausch Health Companies stock | $32.16
Learn how to easily invest in Bausch Health Companies stock.
Bausch Health Companies Inc is a drug manufacturers-specialty & generic business based in the US. Bausch Health Companies shares (BHC) are listed on the NYSE and all prices are listed in US Dollars. Bausch Health Companies employs 21,600 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Bausch Health Companies
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BHC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- BHC shares summary
- Compare share dealing platforms
- Is BHC stock a buy or sell?
- Stock performance over time
- Can I short BHC shares?
- Is BHC suitable for ethical investing?
- Bausch Health Companies's financials
- How volatile are BHC shares?
- Does Bausch Health Companies pay a dividend?
- Have BHC shares ever split?
- Other common questions
Bausch Health Companies stock price (NYSE: BHC)Use our graph to track the performance of BHC stocks over time.
Bausch Health Companies shares at a glance
|Latest market close||$32.16|
|52-week range||$14.86 - $34.80|
|50-day moving average||$29.48|
|200-day moving average||$29.97|
|Wall St. target price||$35.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.86|
Buy Bausch Health Companies shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Bausch Health Companies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Bausch Health Companies price performance over time
|1 week (2021-07-22)||N/A|
|1 month (2021-07-02)||7.59%|
|3 months (2021-04-30)||-0.03%|
|6 months (2021-01-29)||N/A|
|1 year (2020-07-29)||N/A|
|2 years (2019-07-29)||N/A|
|3 years (2018-07-29)||N/A|
|5 years (2016-07-29)||N/A|
Is Bausch Health Companies under- or over-valued?
Valuing Bausch Health Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bausch Health Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bausch Health Companies's EBITDA
Bausch Health Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.2 billion.
The EBITDA is a measure of a Bausch Health Companies's overall financial performance and is widely used to measure a its profitability.
Bausch Health Companies financials
|Revenue TTM||$8 billion|
|Operating margin TTM||17.77%|
|Gross profit TTM||$5.8 billion|
|Return on assets TTM||2.88%|
|Return on equity TTM||-304.51%|
|Market capitalisation||$10.5 billion|
TTM: trailing 12 months
Shorting Bausch Health Companies shares
There are currently 17.2 million Bausch Health Companies shares held short by investors – that's known as Bausch Health Companies's "short interest". This figure is 6% down from 18.3 million last month.
There are a few different ways that this level of interest in shorting Bausch Health Companies shares can be evaluated.
Bausch Health Companies's "short interest ratio" (SIR)
Bausch Health Companies's "short interest ratio" (SIR) is the quantity of Bausch Health Companies shares currently shorted divided by the average quantity of Bausch Health Companies shares traded daily (recently around 1.8 million). Bausch Health Companies's SIR currently stands at 9.76. In other words for every 100,000 Bausch Health Companies shares traded daily on the market, roughly 9760 shares are currently held short.
However Bausch Health Companies's short interest can also be evaluated against the total number of Bausch Health Companies shares, or, against the total number of tradable Bausch Health Companies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Bausch Health Companies's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Bausch Health Companies shares in existence, roughly 50 shares are currently held short) or 0.0565% of the tradable shares (for every 100,000 tradable Bausch Health Companies shares, roughly 57 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Bausch Health Companies.
Find out more about how you can short Bausch Health Companies stock.
Bausch Health Companies's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Bausch Health Companies.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Bausch Health Companies's total ESG risk score
Total ESG risk: 41.19
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Bausch Health Companies's overall score of 41.19 (as at 12/31/2018) is pretty weak – landing it in it in the 89th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Bausch Health Companies is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Bausch Health Companies's environmental score
Environmental score: 3.36/100
Bausch Health Companies's environmental score of 3.36 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Bausch Health Companies is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Bausch Health Companies's social score
Social score: 23.99/100
Bausch Health Companies's social score of 23.99 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Bausch Health Companies is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Bausch Health Companies's governance score
Governance score: 16.84/100
Bausch Health Companies's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that Bausch Health Companies is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Bausch Health Companies's controversy score
Controversy score: 4/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Bausch Health Companies scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that Bausch Health Companies has a damaged public profile.
Environmental, social, and governance (ESG) summary
|Total ESG score||41.19|
|Total ESG percentile||88.8|
|Environmental score percentile||4|
|Social score percentile||4|
|Governance score percentile||4|
|Level of controversy||4|
Bausch Health Companies share dividends
We're not expecting Bausch Health Companies to pay a dividend over the next 12 months.
Have Bausch Health Companies's shares ever split?
Bausch Health Companies's shares were split on a 2:1 basis on 15 October 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Bausch Health Companies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Bausch Health Companies shares which in turn could have impacted Bausch Health Companies's share price.
Bausch Health Companies share price volatility
Over the last 12 months, Bausch Health Companies's shares have ranged in value from as little as $14.86 up to $34.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Bausch Health Companies's is 1.6893. This would suggest that Bausch Health Companies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Bausch Health Companies overview
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States.
Stocks similar to Bausch Health Companies
Bausch Health Companies in the news
Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients
BHC September 10th Options Begin Trading
Why Bausch (BHC) is Poised to Beat Earnings Estimates Again
Frequently asked questionsWhat percentage of Bausch Health Companies is owned by insiders or institutions?
Currently 2.94% of Bausch Health Companies shares are held by insiders and 71.72% by institutions. How many people work for Bausch Health Companies?
Latest data suggests 21,600 work at Bausch Health Companies. When does the fiscal year end for Bausch Health Companies?
Bausch Health Companies's fiscal year ends in December. Where is Bausch Health Companies based?
Bausch Health Companies's address is: 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8 What is Bausch Health Companies's ISIN number?
Bausch Health Companies's international securities identification number is: CA0717341071 What is Bausch Health Companies's CUSIP number?
Bausch Health Companies's Committee on Uniform Securities Identification Procedures number is: 071734107
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert